AI assistant
AtriCure, Inc. — Director's Dealing 2010
Feb 19, 2010
31802_dirs_2010-02-19_da00f6bc-fcee-40d9-8db2-af34d5498c7b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2010-02-17
Reporting Person: Privitera Salvatore (VP Engineering & Product Dev)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-02-17 | Common Stock | A | 11000 | $0.0000 | Acquired | 72026 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-02-17 | Stock Option (right to buy) | $5.5975 | A | 42000 | Acquired | 2020-02-17 | Common Stock (42000) | Direct |
Footnotes
F1: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2005 Equity Incentive Plan. The shares will vest 25% annually over four years from date of grant.
F2: This figure includes 1,500 shares acquired pursuant to the AtriCure, Inc. 2008 Employee Stock Purchase Plan for the period ending December 31, 2009.
F3: The option vests and is exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years.